ScholarIQanswers from OpenAlex
Adjuvant Trastuzumab in HER2-Positive Breast Cancer
PaperCitations, authors & open-access status
Adjuvant Trastuzumab in HER2-Positive Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Adjuvant Trastuzumab in HER2-Positive Breast Cancer have?
ScholarIQcitation count
Adjuvant Trastuzumab in HER2-Positive Breast Cancer has 2,784 citations in the OpenAlex counts ScholarIQ stores.
When was Adjuvant Trastuzumab in HER2-Positive Breast Cancer published?
ScholarIQyear
Adjuvant Trastuzumab in HER2-Positive Breast Cancer has 2011 year in the ScholarIQ index.
What is the open-access status of Adjuvant Trastuzumab in HER2-Positive Breast Cancer?
ScholarIQoa status
Adjuvant Trastuzumab in HER2-Positive Breast Cancer has bronze oa status in the ScholarIQ index.
What is the DOI of Adjuvant Trastuzumab in HER2-Positive Breast Cancer?
ScholarIQdoi
The DOI for Adjuvant Trastuzumab in HER2-Positive Breast Cancer is on the source record.
What is the PMID of Adjuvant Trastuzumab in HER2-Positive Breast Cancer?
ScholarIQpmid
The PMID for Adjuvant Trastuzumab in HER2-Positive Breast Cancer is on the source record.
What is the OpenAlex record for Adjuvant Trastuzumab in HER2-Positive Breast Cancer?
ScholarIQopenalex
The OpenAlex for Adjuvant Trastuzumab in HER2-Positive Breast Cancer is on the source record.